Researchgate nlphl
WebResearchGate is a European commercial social networking site for scientists and researchers [2] to share papers, ask and answer questions, and find collaborators. [3] According to a 2014 study by Nature and a 2016 article in Times Higher Education, it is the largest academic social network in terms of active users, [4] [5] although other ... WebMay 11, 2024 · Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare and clinicopathologically distinct entity within the spectrum of Hodgkin lymphomas …
Researchgate nlphl
Did you know?
WebDec 18, 2024 · Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy associated with excellent survival. However, some patients experience … WebApr 12, 2024 · INTRODUCTION. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a distinctive, uncommon, and generally indolent subtype of Hodgkin lymphoma (HL). NLPHL has characteristic pathologic features, natural history, and management that distinguish it from all other categories of HL, which are collectively referred to as classic …
WebContact Us. We’re currently experiencing a high volume of issues and we ask for your patience in receiving a reply. We encourage you to check if your question is answered on our Help Center before using the form below to contact us. WebApr 12, 2024 · INTRODUCTION. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a distinctive, uncommon, and generally indolent subtype of Hodgkin …
WebJul 31, 2024 · Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma (HL). It shows different histoarchitectural patterns which are reported to be of prognostic significance. This study aimed to investigate the clinicopathological features of NLPHL cases in Shiraz, Iran, and their possible impact on … WebMay 25, 2024 · Of all patients with late stage NLPHL, 107 (21%) died, and 75 (70%) of deaths occurred within 5 years of diagnosis. During the first 5 years after diagnosis, COD was NLPHL in 44 (59%). Beyond 5 years from diagnosis, cardiovascular disease was the COD in 25%, followed by NLPHL (22%). Conclusions: The prognosis of NLPHL is excellent.
WebResearchGate members can create publication pages for their content. If you create a publication page for your work, you are completely in control of it. You can edit it at any time, add or remove a full-text, or delete the page entirely. You can add all kinds of work to ResearchGate, such as conference papers, preprints, or even negative results.
WebNodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity, with limited data on the outcome in the relapsed/refractory setting. We evaluated the outcome of all … how to make private folderWebApr 1, 2024 · Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) and T-cell/histiocyte-rich B-cell lymphoma (T/HRBCL) are distinct tumors and are treated differently. mth448 ubWebDec 24, 2024 · Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity accounting for ∼5% of Hodgkin lymphoma cases. 1 The disease most … how to make private email addressesWebNodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare type of Hodgkin lymphoma (HL) that tends to grow more slowly than classic HL (cHL). It's often treated … mth 4300 baruchWebOct 4, 2024 · The optimal treatment of patients with relapsed or refractory nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is ill defined. To shed more light on … mth4-4/4 a-w-a-aqqvWebSep 29, 2024 · Context.—. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare, indolent Hodgkin lymphoma subtype with distinct clinicopathologic features and treatment paradigms. The neoplastic lymphocyte-predominant cells typically express bright CD20 and other B-cell antigens, which distinguishes them from Hodgkin/Reed-Sternberg … mth 425 ryersonWebApr 12, 2024 · NLPHL accounts for approximately 5 percent of patients diagnosed with Hodgkin lymphoma (HL) . The incidence of NLPHL in the United States and Europe has … mth4-6/3 a-w-a-aqqv